Eldricare

eldricare.com

EldriCare is a population health management company that combines innovative technology with outstanding care management services. We make a difference in people’s lives by effectively engaging them to improve their health. Our expert care teams leverage predictive analytics, the most advanced care management platform in the world, and patient engagement technology to guide, impact, and personalize the care experience.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

CSL PLASMA REIMAGINES DONOR EXPERIENCE WITH FIRST DONATIONS COMPLETED ON INNOVATIVE PLASMA COLLECTION TECHNOLOGY

CSL Plasma | August 08, 2022

news image

CSL Plasma, the plasma collection business of global biotherapeutics leader CSL Behring, began a new era in plasma donations, collecting its first plasma donations using leading-edge plasma collection technology that is expected to significantly reduce average collection time – by approximately one-third – and improve the donor experience. The Rika Plasma Donation System, only available at CSL Plasma and developed by Terumo Blood and Cell Technologies, is designe...

Read More

Cell and Gene Therapy

PHYTOLON AND GINKGO BIOWORKS COLLABORATE TO TAKE BIOLOGICAL PRODUCTION OF VIBRANT FOOD COLORS TO THE NEXT LEVEL

Phytolon; Ginkgo Bioworks | February 28, 2022

news image

Phytolon, a growing startup company making natural food colorants, announced a partnership today with Ginkgo Bioworks the leading horizontal platform for cell programming, to produce vibrant cultured food colors via fermentation of yeast. Under this partnership, Phytolon is leveraging Ginkgo's ability to engineer biology at scale to work together on the production of vibrant betalain pigments, the healthy and colorful compounds found in foods like beets and cactus fruit. The project aims to ...

Read More

Research

POSTERA ANNOUNCES $260M MULTI-TARGET STRATEGIC AI LAB COLLABORATION WITH PFIZER

PostEra | January 12, 2022

news image

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced the expansion of the company's existing strategic collaboration with Pfizer. The expanded multi-target research program will establish an AI Lab where PostEra and Pfizer jointly advance multiple drug discovery programs with an initial focus in oncology and COVID-19 antiviral therapeutics. The AI Lab will leverage novel machine learning for medicinal chemistry built upon Pfizer's da...

Read More

CONCERTAI CREATES COVID-19 RESOURCES FOR ONCOLOGY TO SUPPORT HEALTHCARE PROVIDERS, BIOPHARMACEUTICAL INNOVATORS, AND BIOMEDICAL RESEARCHERS

ConcertAI | October 08, 2020

news image

ConcertAI has launched a set of COVID-19 resources for oncology to support the needs of healthcare providers, biopharmaceutical innovators, and biomedical researchers as they look to maintain patient access to new and critical treatments and improve outcomes during this pandemic. Abstracted sets of aggregated, de-identified real-world data (RWD) will be derived from CancerLinQ Discovery™– a project of CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clin...

Read More
news image

Cell and Gene Therapy

CSL PLASMA REIMAGINES DONOR EXPERIENCE WITH FIRST DONATIONS COMPLETED ON INNOVATIVE PLASMA COLLECTION TECHNOLOGY

CSL Plasma | August 08, 2022

CSL Plasma, the plasma collection business of global biotherapeutics leader CSL Behring, began a new era in plasma donations, collecting its first plasma donations using leading-edge plasma collection technology that is expected to significantly reduce average collection time – by approximately one-third – and improve the donor experience. The Rika Plasma Donation System, only available at CSL Plasma and developed by Terumo Blood and Cell Technologies, is designe...

Read More
news image

Cell and Gene Therapy

PHYTOLON AND GINKGO BIOWORKS COLLABORATE TO TAKE BIOLOGICAL PRODUCTION OF VIBRANT FOOD COLORS TO THE NEXT LEVEL

Phytolon; Ginkgo Bioworks | February 28, 2022

Phytolon, a growing startup company making natural food colorants, announced a partnership today with Ginkgo Bioworks the leading horizontal platform for cell programming, to produce vibrant cultured food colors via fermentation of yeast. Under this partnership, Phytolon is leveraging Ginkgo's ability to engineer biology at scale to work together on the production of vibrant betalain pigments, the healthy and colorful compounds found in foods like beets and cactus fruit. The project aims to ...

Read More
news image

Research

POSTERA ANNOUNCES $260M MULTI-TARGET STRATEGIC AI LAB COLLABORATION WITH PFIZER

PostEra | January 12, 2022

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced the expansion of the company's existing strategic collaboration with Pfizer. The expanded multi-target research program will establish an AI Lab where PostEra and Pfizer jointly advance multiple drug discovery programs with an initial focus in oncology and COVID-19 antiviral therapeutics. The AI Lab will leverage novel machine learning for medicinal chemistry built upon Pfizer's da...

Read More
news image

CONCERTAI CREATES COVID-19 RESOURCES FOR ONCOLOGY TO SUPPORT HEALTHCARE PROVIDERS, BIOPHARMACEUTICAL INNOVATORS, AND BIOMEDICAL RESEARCHERS

ConcertAI | October 08, 2020

ConcertAI has launched a set of COVID-19 resources for oncology to support the needs of healthcare providers, biopharmaceutical innovators, and biomedical researchers as they look to maintain patient access to new and critical treatments and improve outcomes during this pandemic. Abstracted sets of aggregated, de-identified real-world data (RWD) will be derived from CancerLinQ Discovery™– a project of CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clin...

Read More